Time course of improvement of different symptom clusters in patients with major depression and pain treated with duloxetine or placebo

Current Medical Research and Opinion

Volumn 28, Issue 1, 2012, Pages 41-48

  Demyttenaere, Koen ^a   Desaiah, Durisala ^b   Petit, Claude ^c   Croenlein, Jens ^d   Brecht, Stephan ^d  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b ELI LILLY AND COMPANY   (United States)

^c BOEHRINGER INGELHEIM PHARMACEUTICALS INC   (United States)

^d BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

Author keywords

Depression; Duloxetine; Pain; Symptom cluster; Time course

Indexed keywords

DULOXETINE; PLACEBO;

ANGER; ARTICLE; BRIEF PAIN INVENTORY; CONTROLLED STUDY; DISEASE SEVERITY; DRUG DOSE ESCALATION; DRUG DOSE REDUCTION; FEMALE; HOSTILITY; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MONTGOMERY ASBERG DEPRESSION RATING SCALE; OBSESSIVE COMPULSIVE DISORDER; PAIN; PARANOIA; PHOBIA; POST HOC ANALYSIS; PSYCHOSIS; SOMATIZATION; SYMPTOM CHECKLIST 90;

ADULT; ANTIDEPRESSIVE AGENTS; DEPRESSIVE DISORDER, MAJOR; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MULTICENTER STUDIES AS TOPIC; PAIN; PAIN MEASUREMENT; PLACEBOS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; THIOPHENES; TIME FACTORS; TREATMENT OUTCOME;

EID: 84855953276     PISSN: 03007995     EISSN: 14734877     Source Type: Journal    
DOI: 10.1185/03007995.2011.645561     Document Type: Article

References (37)

1. Löwe B, Spitzer RL, Williams JB, et al. Depression, anxiety and somatization in primary care: syndrome overlap and functional impairment. Gen Hosp Psychiatry 2008;30:191-9 (Pubitemid 351538962)
2. Leuchter AF, Husain MM, Cook IA, et al. Painful physical symptoms and treatment outcome in major depressive disorder: a STAR*D (Sequenced Treatment Alternatives to Relieve Depression) report. Psychol Med 2010;40:239-51
3. Fava M, Alpert JE, Carmin CN, et al. Clinical correlates and symptom patterns of anxious depression among patients with major depressive disorder in STAR*D. Psychol Med 2004;34:1299-308 (Pubitemid 39517160)
4. Bair MJ, Robinson RL, Eckert GJ, et al. Impact of pain on depression treatment response in primary care. Psychom Med 2004;66:17-22 (Pubitemid 38146528)
5. Kroenke K, Shen J, Oxman TE, et al. Impact of pain on the outcomes of depression treatment: results from the RESPECT trial. Pain 2008;134:209-15 (Pubitemid 350251018)
6. Demyttenaere K, Bonnewyn A, Bruffaerts R, et al. Comorbid painful physical symptoms and depression: prevalence, work loss, and help seeking. J Affect Disord 2006;92:185-93
7. Demyttenaere K, Bonnewyn A, Bruffaerts R, et al. Comorbid painful physical symptoms and anxiety: prevalence, work loss and help-seeking. J Affect Disord 2008;109:264-72
8. Chung KF, Tso KC, Yeung WF, et al. Quality of life in major depressive disorder: the role of pain and pain catastrophizing cognition. Compr Psychiatry 2011; [Epub ahead of print]
9. Fava M, Rush AJ, Alpert JE, et al. Difference in treatment outcome in outpatients with anxious versus nonanxious depression: a STAR*D report. Am J Psychiatry 2008;165:342-51 (Pubitemid 351704490)
10. Finnerup NB, Sindrup SH, Jensen TS. The evidence for pharmacological treatment of neuropathic pain. Pain 2010;150:573-81
11. Greco T, Eckert G, Kroenke K. The outcome of physical symptoms with treatment of depression. J Gen Intern Med 2004;19:813-18 (Pubitemid 39096352)
12. Trivedi MH, Morris DW, Grannemann BD, et al. Symptom clusters as predictors of late response to antidepressant treatment. J Clin Psychiatry 2005;66:1064-70 (Pubitemid 41191801)
13. Stassen HH, Delini-Stula A, Angst J. Time course of improvement under antidepressant treatment: a survival-analytical approach. Eur Neuropsychopharmacol 1993;3:127-35 (Pubitemid 24089502)
14. Uher R, Muthé n B, Souery D, et al. Trajectories of change in depression severity during treatment with antidepressants. Psychol Med 2010;40:1367-77
15. Poirier MF, Boyer P. Venlafaxine and paroxetine in treatment-resistant depression. Double-blind, randomized comparison. Br J Psychiatry 1999;175:12-16 (Pubitemid 29307849)
16. Brecht S, Courtecuisse C, Debieuvre C, et al. Efficacy and safety of duloxetine 60 mg once daily in the treatment of pain in patients with major depressive disorder and at least moderate pain of unknown etiology: a randomized controlled trial. J Clin Psychiatry 2007;68:1707-16 (Pubitemid 350247500)
17. Hudson JI, Perahia DG, Gilaberte I, et al. Duloxetine in the treatment of major depressive disorder: an open-label study. BMC Psychiatry 2007;7:43-53
18. Shelton RC, Prakash A, Mallinckrodt CH, et al. Patterns of depressive symptom response in duloxetine-treated outpatients with mild, moderate or more severe depression. Int J Clin Pract 2007;61:1337-48 (Pubitemid 47052368)
19. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th edn. Washington, DC: American Psychiatric Association, 1994
20. Sheehan DV, Lecrubier Y, Sheehan KH, et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 1998;59:22-33 (Pubitemid 29001829)
21. Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry 1979;134:382-9 (Pubitemid 9136500)
22. SCL-90 Self-Report Symptom Inventory. In: Guy W, ed., ECDEU Assessment Manual for Psychopharmacology, revised edn. Rockville, MD: National Institute of Mental Health, 1976:314-30
23. Derogatis LR, Lipman RS, Rickels K, et al. The Hopkins Symptom Check List (HSCL): a self-report symptom inventory. Behav Sci 1974; 19:1-15
24. Cleeland CS, Ryan KM. Pain assessment global use of the Brief Pain Inventory. Ann Acad Med Singap 1994; 23:129-38
25. Demyttenaere K, Desaiah D, Petit C, et al. Patient-assessed versus physicianassessed disease severity and outcome in patients with nonspecific pain associated with major depressive disorder. Prim Care Companion. J Clin Psychiatry 2009;11:8-15
26. Moncrieff J. The antidepressant debate. Br J Psychiatry 2002;180:193-4
27. Ostelo RW, Deyo RA, Stratford P, et al. Interpreting change scores for pain and functional status in low back pain: towards international consensus regarding minimal important change. Spine (Phila Pa 1976) 2008;33:90-4
28. ten Klooster PM, Drossaers-Bakker KW, Taal E, et al. Patient-perceived satisfactory improvement (PPSI): interpreting meaningful change in pain from the patient's perspective. Pain 2006;121:151-7 (Pubitemid 43261642)
29. Partiot A, Jouvent R, Pierson A, et al. Are there differential effects of fluoxetine in retarded/blunted affect versus agitated/anxious depressives? A clinical study. Eur Psychiatry 1997;12:21-7 (Pubitemid 27061064)
30. Yang Z, Zhao J, Jiang Y, et al. Altered negative unconscious processing in major depressive disorder: an exploratory neuropsychological study. PLoS One 2011;6(7):e21881
31. Harmer CJ, Goodwin GM, Cowen PJ. Why do antidepressants take so long to work? A cognitive neuropsychological model of antidepressant drug action. Br J Psychiatry 2009;195:102-8
32. Mayberg HS, Silva JA, Brannan SK, et al. The functional neuroanatomy of the placebo effect. Am J Psychiatry 2002;159:728-37 (Pubitemid 34465045)
33. Moncrieff J, Cohen D. Rethinking models of psychotropic drug action. Psychother Psychosom 2005;74:145-53 (Pubitemid 41094845)
34. Paykel ES, Price JS, Gillan RU, et al. A comparative trial of imipramine and chlorpromazine in depressed patients. Br J Psychiatry 1968; 114:1281-7
35. Raskin A, Schulterbrandt JG, Reatig N, et al. Differential response to chlorpromazine, imipramine, and placebo. A study of subgroups of hospitalized depressed patients. Arch Gen Psychiatry 1970;23:164-7
36. Lin EH, Katon W, Von Korff M, et al. Effect of improving depression care on pain and functional outcomes among older adults with arthritis: a randomized controlled trial. JAMA 2003;290:2428-9
37. Perahia DG, Pritchett YL, Desaiah D, et al. Efficacy of duloxetine in painful symptoms: an analgesic or antidepressant effect? Int Clin Psychopharmacol 2006;21:311-17 (Pubitemid 44498273)